V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Debut trading of Kinnate Biopharma, Inc.

04.12.2020

In their debut trading on Thursday December 3, 2020 Kinnate Biopharma, Inc (KNTE) showed a 95.15% increase and closed at $39.03 per share. Shortly before the company had placed its shares in an IPO priced $20 per share.